Qlife Holding AB (OSTO:QLIFE) Debt-to-Asset : 0.08 (As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Qlife Holding AB Debt-to-Asset?

Qlife Holding AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was kr6.37 Mil. Qlife Holding AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was kr4.86 Mil. Qlife Holding AB's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2023 was kr150.01 Mil. Qlife Holding AB's debt to asset for the quarter that ended in Sep. 2023 was 0.07.

Qlife Holding AB Debt-to-Asset Historical Data

The historical data trend for Qlife Holding AB's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qlife Holding AB Debt-to-Asset Chart

Qlife Holding AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Debt-to-Asset

0.06

0.19

0.03

0.27

Qlife Holding AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Debt-to-Asset	Get a 7-Day Free Trial														0.35	0.27	0.32	0.05	0.08

Competitive Comparison of Qlife Holding AB's Debt-to-Asset

For the Medical Devices subindustry, Qlife Holding AB's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Qlife Holding AB's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Qlife Holding AB's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Qlife Holding AB's Debt-to-Asset falls into.

Qlife Holding AB Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Qlife Holding AB's Debt-to-Asset for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(4.148	+	48.293)	/	192.65
	=	0.27

Qlife Holding AB's Debt-to-Asset for the quarter that ended in Sep. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(6.371	+	4.855)	/	150.009
	=	0.07

Qlife Holding AB (OSTO:QLIFE) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Qlife Holding AB Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Qlife Holding AB's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Qlife Holding AB (OSTO:QLIFE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Qlife Holding AB (OSTO:QLIFE) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

4HG:Germany

Address

Redaregatan 48, Helsingborg, SWE, SE-252 36

Website

https://www.qlifeholding.com

Qlife Holding AB is a medical device company that seeks to revolutionize the clinical biomarker testing of whole blood by taking it out of the lab and into the homes of the people who needs it. The Egoo Home System is an integrated platform consisting of a small home device and disposable capsules, each of which tests for a specific biomarker. It provides a digital infrastructure for sharing the data with the patient's doctor, clinic or hospital via smartphone and computer.

Qlife Holding AB (OSTO:QLIFE) Headlines

No Headlines